Lachey Jennifer 4
4 · Keros Therapeutics, Inc. · Filed Jul 19, 2022
Insider Transaction Report
Form 4
Lachey Jennifer
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-07-15$0.30/sh+46,034$13,810→ 141,134 total - Sale
Common Stock
2022-07-15$30.00/sh−46,034$1,381,020→ 95,100 total - Exercise/Conversion
Employee Stock Option (right to buy)
2022-07-15−46,034→ 8,755 totalExercise: $0.30Exp: 2028-03-25→ Common Stock (46,034 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Immediately exercisable.